SM
REGN icon

SG3 Management’s Regeneron Pharmaceuticals REGN Stock Holding History

SG3 Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– – – 392
2022
Q3 		– Hold
0
– – – 524
2022
Q1 		– Sell
-200
Closed -$126K – 1565
2021
Q4 		$126K Sell
200
-300
-60% -$184K 0.01% 884
2021
Q3 		$303K Buy
500
+200
+67% +$124K 0.11% 703
2021
Q2 		$168K Buy
+300
New +$152K 0.07% 849
2021
Q1 		– Hold
0
– – – 1692
2020
Q4 		– Hold
0
– – – 1414
2018
Q1 		– Hold
0
– – – 183
2017
Q4 		– Hold
0
– – – 251
2017
Q3 		– Hold
0
– – – 335
2017
Q2 		– Hold
0
– – – 393

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return